BackPear Therapeutics Overview

Pear Therapeutics Total Liabilities

Track Pear Therapeutics's total liabilities ($65M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$64.54M
39.52% YoYΔ $-42.18M vs prior year quarter

Peer average

Loading

Pear Therapeutics Total Liabilities History

Loading

Pear Therapeutics vs. peers: Total Liabilities Comparison

Loading

Pear Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pear Therapeutics (PEAR) FAQ

As of the most recent data (December 2022), PEAR shows a total liabilities of $65M. That compares with $110M in the prior-year period — down 39.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEAR's total liabilities is now $65M (was $110M) — a 39.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics is outperforming or lagging.

Tracking PEAR's total liabilities over time shows whether Pear Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $65M That compares with $110M in the prior-year period — down 39.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Pear Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $65M) with ownership activity and broader fundamentals.